| Description | This is a human IgG1 antibody that directed against human C-type lectin, which has an amino acid sequence of 275 amino acids. Studies have found that human C-type lectins are expressed only by myeloid cells and not by lymphocytes and other cell types. This makes human C-type lectins suitable target molecules for binding molecules, particularly immunoconjugates, for the research of myeloid neoplastic diseases such as AML and CML. |
| Clonality | Monoclonal |
| Host Species | Human |
| Target Species | Human |
| Epitope | Amino acids 1-10 |
| Isotype | Human IgG1 |
| Expression Species | HEK293F or CHO |
| Conjugation | None |
| Purity | >95%, determined by SDS-PAGE and SEC-HPLC |
| Endotoxin | <1 EU/mg |
| Purification | Protein A affinity purified |
| Sterility | 0.2 μM filtered |
| Formulation | PBS, pH 7.4 |
| Preservation | No preservatives |
| Stabilizer | No stabilizers |
| Storage | Store at 4°C within a week. For longer storage, aliquot and store at -20°C. |
| Application | IHC; FC |
| Application Notes | FC: 1-50 μg/mL |
| ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
| WB | Western Blot Protocol |
| FC | Flow Cytometry Protocol |
| Target | CLEC |
| Alternative Name | C-type lectin; CLEC |
| Research Area | Neuroscience |
| Related Disease | Neoplastic disorders and diseases |
